Mahindra Group registers interest to seek Covid-19 vaccines for employees

Diversified Mahindra Group on Friday said it has registered interest to seek COVID-19 vaccines for its employees, as per priorities and sequence to be specified by the government.

The farm equipment-to-aerospace conglomerate said it would take the responsibility for the inoculation of its employees rather than have the government subsidise them.

"We have registered our interest to seek vaccines for our employees, in accordance with the priorities and sequence to be specified by the government," a Mahindra Group spokesperson said in a statement.

The spokesperson further said, "We believe it is our duty to take responsibility for the inoculation of our employees, rather than have the government subsidise them."

India is all set to roll out the world's biggest vaccination programme on Saturday with over 3 lakh healthcare workers to be inoculated on the first day of the much-anticipated drive against coronavirus.

The vaccination drive has been planned in a phased manner, identifying priority groups. Healthcare workers, both in government and private sectors including ICDS (Integrated Child Development Services) workers, will receive the vaccine during this phase, according to the health ministry.

Mahindra Group has presence in over 100 countries, employing over 2.5 lakh people.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel